Outsourcing in Drug Discovery, 3rd Edition – New Market Analysis
June 18, 2009
2009-06-16 17:57:04 – Outsourcing in Drug Discovery, 3rd Edition – a new market research report on companiesandmarkets.com
2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. There is increasing pressure to develop new lead compounds due to the near-term loss of patent protection for many drug product. And there is also
pressure to reduce the time spent in drug discovery and to bring drugs to market sooner, as well as the ever-present cost considerations.
The Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore suppliers is covered in detail. The report also provides profiles of 23 suppliers, representative of those active in this market.
Segments covered in this report include:
Chemistry Services
Building Blocks
Compound Synthesis
Libraries
Process Research
Other Services
Biology Services
Protein Expression
Structural Analysis
Target Validation
Pathways Analysis
Other Services
Screening Services
Assay Development
Primary Screening
Secondary Screening
Lead Optimization
Early ADMET
Analogues Creation
Computational Support
Other services
In addition to market data and forecasts, the report covers issues such as:
What factors should a client consider when deciding whether to do a project in-house or outsource it?
Is it in the client´s best interest to seek a domestic outsourcing partner, or go with an overseas supplier?
How does the client select the CRO that is best for him?
What are the best practices when working with a CRO?
How do you measure his effectiveness?
How do you avoid problems with your CRO?
How do you maximize benefits?
This report looks offshore at outsourcing suppliers based in three major areas: India, China, and Eastern Europe. The relative advantages each country provides are contrasted with some of their limitations. The report asses which projects are moving to which suppliers and why.
-
Advertisements
Text Links
